BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 12554376)

  • 1. Alginate-diltiazem hydrochloride beads: optimization of formulation factors, in vitro and in vivo availability.
    El-Kamel AH; Al-Gohary OM; Hosny EA
    J Microencapsul; 2003; 20(2):211-25. PubMed ID: 12554376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
    al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
    Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the pharmaceutical properties of sustained-release gel beads prepared by alginate having different molecular size with commercial sustained-release tablet.
    Imai T; Kawasaki C; Nishiyama T; Otagiri M
    Pharmazie; 2000 Mar; 55(3):218-22. PubMed ID: 10756544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling of systemic absorption of gliclazide through incorporation into alginate beads.
    Al-Kassas RS; Al-Gohary OM; Al-Faadhel MM
    Int J Pharm; 2007 Aug; 341(1-2):230-7. PubMed ID: 17507189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of beads made of different calcium alginate compositions for oral sustained release of tiaramide.
    Fathy M; Safwat SM; el-Shanawany SM; Shawky Tous S; Otagiri M
    Pharm Dev Technol; 1998 Aug; 3(3):355-64. PubMed ID: 9742556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride.
    Mandal S; Ray R; Basu SK; Sa B
    J Biomater Sci Polym Ed; 2010; 21(13):1799-814. PubMed ID: 20557689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in vitro characterization of diltiazem hydrochloride loaded alginate microspheres.
    Sultana Y; Mall S; Maurya DP; Kumar D; Das M
    Pharm Dev Technol; 2009; 14(3):321-31. PubMed ID: 19235550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release behaviour of diclofenac sodium dispersed in Gelucire and encapsulated with alginate beads.
    Al-Taani B; Khanfar MS; Salem MS; Sallam A
    J Microencapsul; 2010; 27(1):10-3. PubMed ID: 20078392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
    Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
    Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Entrapment efficiency and release characteristics of polyethyleneimine-treated or -untreated calcium alginate beads loaded with propranolol-resin complex.
    Halder A; Maiti S; Sa B
    Int J Pharm; 2005 Sep; 302(1-2):84-94. PubMed ID: 16102927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of drug release from glyceryl palmitostearate-alginate beads via heat treatment.
    Pongjanyakul T; Sungthongjeen S; Puttipipatkhachorn S
    Int J Pharm; 2006 Aug; 319(1-2):20-8. PubMed ID: 16677785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel interpenetrated polymer network microbeads of natural polysaccharides for modified release of water soluble drug: in-vitro and in-vivo evaluation.
    Kulkarni RV; Mutalik S; Mangond BS; Nayak UY
    J Pharm Pharmacol; 2012 Apr; 64(4):530-40. PubMed ID: 22420659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and characterization of calcium alginate beads containing ampicillin.
    Torre ML; Giunchedi P; Maggi L; Stefli R; Machiste EO; Conte U
    Pharm Dev Technol; 1998 May; 3(2):193-8. PubMed ID: 9653756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and release characteristics of polymer-coated and blended alginate microspheres.
    Lee DW; Hwang SJ; Park JB; Park HJ
    J Microencapsul; 2003; 20(2):179-92. PubMed ID: 12554373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
    Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
    Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entrapment of andrographolide in cross-linked alginate pellets: I. Formulation and evaluation of associated release kinetics.
    Shariff A; PK M; KLK P; M M
    Pak J Pharm Sci; 2007 Jan; 20(1):1-9. PubMed ID: 17337420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of furosemide-loaded alginate microspheres prepared by ionotropic external gelation technique.
    Das MK; Senapati PC
    Acta Pol Pharm; 2007; 64(3):253-62. PubMed ID: 17695149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
    Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
    Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionotropic gelation: encapsulation of indomethacin in calcium alginate gel discs.
    Pillay V; Dangor CM; Govender T; Moopanar KR; Hurbans N
    J Microencapsul; 1998; 15(2):215-26. PubMed ID: 9532527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
    Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.